Bee Venom Phospholipase A2: Yesterday’s Enemy Becomes Today’s Friend
Bee venom therapy has been used to treat immune-related diseases such as arthritis for a long time. Recently, it has revealed that group III secretory phospholipase A2 from bee venom (bee venom group III sPLA2) has in vitro and in vivo immunomodulatory effects. A growing number of reports have demon...
Main Authors: | Gihyun Lee, Hyunsu Bae |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-02-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/8/2/48 |
Similar Items
-
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A2 in Mice
by: Dasom Shin, et al.
Published: (2016-04-01) -
Bee Venom Phospholipase A2 Ameliorates Atherosclerosis by Modulating Regulatory T Cells
by: Geun-Hyung Kang, et al.
Published: (2020-09-01) -
Analgesic Effects of Bee Venom Derived Phospholipase A2 in a Mouse Model of Oxaliplatin-Induced Neuropathic Pain
by: Dongxing Li, et al.
Published: (2015-06-01) -
Bee Venom Phospholipase A2 Induces Regulatory T Cell Populations by Suppressing Apoptotic Signaling Pathway
by: Hyunjung Baek, et al.
Published: (2020-03-01) -
Prophylactic Effects of Bee Venom Phospholipase A2 in Lipopolysaccharide-Induced Pregnancy Loss
by: Hyunjung Baek, et al.
Published: (2019-07-01)